Starsource Multitrade

Starsource Multitrade Earnings Yield

The Earnings Yield of Starsource Multitrade (506365.BO) as of Oct 20, 2026 is -69.85 %. In the previous year, Earnings Yield was 2.02 % — a change of -3,563.33% (lower).

Earnings Yield

-69.85 %

YoY

-3,563.33%

Last updated:

Earnings Yield of Starsource Multitrade is 2026 -69.85 % . Earnings Yield of Starsource Multitrade was 2025 2.02 % . It decreases by -3,563.33% lower compared to the previous year.

The Starsource Multitrade Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2019
1.22 INR
Jan 1, 2020
2.45 INR
Jan 1, 2021
1.47 INR
Jan 1, 2022
3.30 INR
Jan 1, 2023
0.28 INR
Jan 1, 2024
7.07 INR
Jan 1, 2025
2.02 INR
Jan 1, 2026
-69.85 INR
The Starsource Multitrade Earnings Yield history
YEAREarnings YieldYoY
-69.85 %-3,563.33%
2.02 %-71.48%
7.07 %+2,437.62%
0.28 %-91.55%
3.30 %+123.91%
1.47 %-39.76%
2.45 %+101.25%
1.22 %+105.00%
0.59 %-97.85%
27.60 %-423.32%
-8.54 %-617.59%
1.65 %+16.06%
1.42 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Earnings Yield of Starsource Multitrade is -69.85 % in 2026.

Earnings Yield of Starsource Multitrade changed from 2.02 % to -69.85 %, representing a -3,563.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Starsource Multitrade with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Starsource Multitrade

All Key Metrics — Starsource Multitrade